ADSTILADRIN
nadofaragene firadenovec-vncg
Listed by Ferring Pharmaceuticals Inc.
- Strength
- 300000000000 {VP}/mL
- Form
- Suspension
- Route
- Intravesical
What it contains
- Nadofaragene Firadenovec 300000000000 {VP}/mL
FDA record
| Dosage form | Suspension |
|---|---|
| Route | Intravesical |
| Approval route | BLA — biologic licence |
| NDC code | 55566-1050 |
| FDA application | BLA125700 |
| RxNorm concept | 2644440 |
| Package sizes listed | 2 |
| Marketed since | September 2023 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.